# GHRS catalysts: GH Research PLC PDUFA dates and FDA events

Canonical: https://sec-api.dev/companies/ghrs/catalysts

> GH Research PLC (GHRS) has no upcoming catalysts in this calendar. The latest recorded is the mebufotenin topline data readout, Q1 2025.

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: quarter only.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Verified answer

### What are the upcoming FDA catalysts for GHRS?

GH Research PLC (GHRS) has no upcoming catalysts in this calendar. The latest recorded is the mebufotenin topline data readout, Q1 2025. Press release filed with the SEC (EX-99): "2024, with top-line data on track to be announced in the first quarter of 2025." [Calendar and source filings](https://sec-api.dev/companies/ghrs/catalysts)

Source: Press release filed with the SEC (EX-99), accession 0001140361-25-000705, https://www.sec.gov/Archives/edgar/data/1855129/000114036125000705/ef20041294_ex99-1.htm (retrieved 2026-11-12). Last confirmed 2025-01-10. Cite: https://sec-api.dev/companies/ghrs/catalysts#answer

## Company

| Field | Value |
| --- | --- |
| Name | GH Research PLC |
| Ticker | GHRS (Nasdaq) |
| SEC CIK | 1855129 |
| SIC | 2834 |
| SEC filings | https://sec-api.dev/companies/ghrs |

## Catalysts

| Date | Event | Ticker | Indication | Status | Source sentence |
| --- | --- | --- | --- | --- | --- |
| Q4 2024 | [Mebufotenin topline data readout](https://sec-api.dev/pdufa/mebufotenin) | GHRS |  | scheduled | "We completed enrolment of the double-blind phase in the third quarter of 2024, with top-line data expected to be available in the fourth quarter of 2024 or the first quarter of 2025." ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/1855129/000114036124046715/ef20035537_ex99-2.htm)) |
| Q1 2025 | [Mebufotenin topline data readout](https://sec-api.dev/pdufa/mebufotenin) | GHRS |  | scheduled | "2024, with top-line data on track to be announced in the first quarter of 2025." ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/1855129/000114036125000705/ef20041294_ex99-1.htm)) |

## Drugs

- [Mebufotenin](https://sec-api.dev/pdufa/mebufotenin): 

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/companies/ghrs/catalysts.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "GHRS catalysts: GH Research PLC PDUFA dates and FDA events." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/companies/ghrs/catalysts

```bibtex
@misc{secapidev_companies_ghrs_catalysts_20261116,
  title        = {GHRS catalysts: GH Research PLC PDUFA dates and FDA events},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/companies/ghrs/catalysts}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_companies_ghrs_catalysts_20261116","title":"GHRS catalysts: GH Research PLC PDUFA dates and FDA events","publisher":"sec-api.dev","URL":"https://sec-api.dev/companies/ghrs/catalysts","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
